PI3K/Akt inhibition modulates multidrug resistance and activates NF-κB in murine lymphoma cell lines
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Upregulation of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway has been described in some tumors related to multidrug resistance (MDR). The aim of this work was to analyze the relationship between PI3K/Akt, MDR and NF-kappaB in murine lymphoma cell lines resistant to vincristine (LBR-V160) and doxorubicin (LBR-D160) as well as in the sensitive line (LBR-). PI3K/Akt activity, analyzed by phosphatidylinositol trisphosphate production and phosphorylated Akt (p-Akt) expression, was higher in the resistant cell lines than in the sensitive one and inhibition with wortmannin or LY294002 improved apoptosis in the resistant cell lines. Vincristine but not doxorubicin increased p-Akt expression whereas co-treatment with PI3K inhibitors and vincristine increased apoptosis in the three cell lines. Wortmannin and LY294002 inhibited P-glycoprotein (Pgp) function and also increased NF-kappaB activity. We concluded that the PI3K/Akt pathway is involved in MDR in lymphoma cell lines and PI3K/Akt inhibition correlates down-regulation of NF-kappaB activity and inhibition Pgp function.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Guha, M., & Mackman, N. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203298200 · Cited by 799
The molecular basis of multidrug resistance in cancer: The early years of P‐glycoprotein research
Gottesman, M. M., & Ling, V. (2006) · FEBS Letters · doi:10.1016/j.febslet.2005.12.060 · Cited by 558 · cited 2×
“Their function is to extrude antituor agents from the cytoplasm, thus reducing intracellular rug concentrations to sublethal levels [1].”
Background
Cited by
Iliopoulos, D., Jaeger, S. A., Hirsch, H. A., Bulyk, M. L., & Struhl, K. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.07.023 · Cited by 830
“Lastly, the PTEN/Akt pathway regulates NF-kB activity in cancer cells, PTEN deletion results in increased NF-kB activity (Garcı́a et al., 2009; Guigon et al., 2009), and inhibition of Akt expression reduces NF-kB activity and IL-6 , August 27, 2010 ª2010 Elsevier Inc. 499 production (Figures S4E…”
BackgroundModulation of P-glycoprotein efflux pump: induction and activation as a therapeutic strategy
Silva, R., Vilas-Boas, V., Carmo, H., Dinis-Oliveira, R. J., Carvalho, F., de Lourdes Bastos, M., & Remião, F. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.11.013 · Cited by 339
Bexarotene: A promising anticancer agent
Qu, L., & Tang, X. (2010) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-009-1140-4 · Cited by 78
Martins, A., Tóth, N., Ványolós, A., Béni, Z., Zupkó, I., Molnár, J., Báthori, M., & Hunyadi, A. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300424n · Cited by 59
Gérard, C., Gonze, D., Lemaigre, F., & Novák, B. (2014) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1003455 · Cited by 20
“Actually, PTEN down-regulates Akt, which activates NF-kB [20,36,37].”
Metadata
- Authors
- García, M. G., Alaniz, L. D., Cordo Russo, R. I., Alvarez, E., & Hajos, S. E.
- Venue
- Leukemia Research
- Publisher
- Elsevier BV
- Published
- 2009-02
- Volume
- 33
- Issue
- 2
- Pages
- 288-296
- ISSN
- 0145-2126 (ISSN-L)
- OpenAlex
- W2049767023
- Cited by
- 77
- References
- 2
- FWCI
- 3.23
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: PI3K/Akt inhibition modulates multidrug resistance and activates NF-κB in murine lymphoma cell lines. https://app.cochat.ai/papers/10.1016/j.leukres.2008.06.010
- The paper
- García, M. G., Alaniz, L. D., Cordo Russo, R. I., Alvarez, E., & Hajos, S. E. (2009). PI3K/Akt inhibition modulates multidrug resistance and activates NF-κB in murine lymphoma cell lines. Leukemia Research. https://doi.org/10.1016/j.leukres.2008.06.010
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.